The groundbreaking treatment of this peptide represents a significant development in the handling of type 2 diabetes. Different to existing drugs, tirzepatide targets dual pathways – GLP-1 and glucose-dependent https://tirzepatide-peptide508183.actoblog.com/42967524/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment